Sou Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Syèj251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Fonde2018
EstatiAktif
Brevè1 brevè
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Evalyasyon
Poko gen avi. Ou te travay ak Assertio Therapeutics, Inc.? Se premye moun ki pataje eksperyans ou.
Enfòmasyon legal
| Non legal | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Wè sou GLEIF ↗ |
| Adrès anrejistre | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Estati | Aktif |
Sous: GLEIF · mete ajou Oct. 16, 2026
Kontak & lyen
Kote
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Èske se konpayi ou?
Reklame paj sa a gratis pou ajoute logo, pwodwi, foto ak travay ou, epi pou reponn avi yo.
Reklame paj sa aAntre nan Heelky pou konekte, anboche epi grandi
Kreye yon kont gratis pou voye mesaj bay moun, aplike pou travay epi pibliye misyon.
Antre kounye a — li gratis